Literature DB >> 12190132

Primary tumour resection of tongue carcinoma based on response to preoperative therapy.

T Kirita1, K Ohgi, M Kawakami, S Miyawaki, M Okamoto, Y Yamanaka, M Sugimura.   

Abstract

The purpose of this study was to investigate the selection of resection techniques for primary lesions of advanced tongue carcinoma based on the effectiveness of our current preoperative therapy. Forty-three patients with advanced but potentially resectable squamous cell carcinoma of the tongue were included in this study. All patients were treated with preoperative concurrent chemoradiotherapy followed by conventional surgical resection. Semiserial sections of whole surgical specimen of primary lesion were evaluated histopathologically. In patients who achieved 85% and above regression, the extent of residual tumours two-dimensionally and in the deep layers was lesser, and the rate of tumour cell survival was lower, than in other patients. Furthermore, residual tumours tended to be localized to the superficial layers in the centre. These findings suggest that even in advanced tongue carcinomas it is possible to avoid extended resection and perform a less invasive surgery in which the extent of resection is reduced to preserve morphology and function in patients who achieved 65% and above regression following preoperative chemoradiotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190132     DOI: 10.1054/ijom.2002.0241

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  2 in total

1.  Predictors of locoregional recurrence in T1-2N0 tongue cancer patients.

Authors:  Souichi Yanamoto; Shin-ichi Yamada; Hidenori Takahashi; Goro Kawasaki; Hisazumi Ikeda; Takeshi Shiraishi; Shuichi Fujita; Tohru Ikeda; Izumi Asahina; Masahiro Umeda
Journal:  Pathol Oncol Res       Date:  2013-05-17       Impact factor: 3.201

2.  Analysis of the outcome of concurrent neoadjuvant chemoradiotherapy with S-1 compared to super-selective intra-arterial infusion for oral squamous cell carcinoma.

Authors:  Akihiko Miyawaki; Hiroshi Hijioka; Ryuji Ikeda; Takayuki Ishida; Etsuro Nozoe; Norifumi Nakamura
Journal:  Oncol Lett       Date:  2012-02-13       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.